New Standard of Care in PD-L1+ Esophageal Cancer? New Standard of Care in PD-L1+ Esophageal Cancer?

Patients with advanced esophageal cancer who have a high level of PD-L1 showed improved survival on poembrolizumab compared to standard chemotherapy.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news